Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$11.23 - $19.59 $943,320 - $1.65 Million
-84,000 Closed
0 $0
Q1 2022

May 17, 2022

SELL
$13.37 - $17.79 $506,722 - $674,241
-37,900 Reduced 31.09%
84,000 $1.37 Million
Q4 2021

Feb 15, 2022

SELL
$14.28 - $19.53 $275,604 - $376,929
-19,300 Reduced 13.67%
121,900 $1.99 Million
Q3 2021

Nov 16, 2021

BUY
$12.99 - $20.47 $898,908 - $1.42 Million
69,200 Added 96.11%
141,200 $2.1 Million
Q2 2021

Aug 16, 2021

BUY
$15.46 - $24.5 $742,080 - $1.18 Million
48,000 Added 200.0%
72,000 $1.44 Million
Q1 2021

May 18, 2021

SELL
$19.33 - $37.75 $1.26 Million - $2.47 Million
-65,300 Reduced 73.12%
24,000 $554,000
Q4 2020

Feb 17, 2021

BUY
$24.48 - $42.47 $653,616 - $1.13 Million
26,700 Added 42.65%
89,300 $2.21 Million
Q3 2020

Nov 17, 2020

SELL
$39.09 - $53.44 $3.94 Million - $5.39 Million
-100,800 Reduced 61.69%
62,600 $2.6 Million
Q2 2020

Aug 17, 2020

BUY
$46.7 - $92.04 $6.84 Million - $13.5 Million
146,400 Added 861.18%
163,400 $7.83 Million
Q1 2020

May 15, 2020

SELL
$48.35 - $118.68 $3.2 Million - $7.86 Million
-66,200 Reduced 79.57%
17,000 $1.07 Million
Q4 2019

Feb 14, 2020

BUY
$57.36 - $124.1 $4.61 Million - $9.97 Million
80,300 Added 2768.97%
83,200 $10.3 Million
Q2 2019

Aug 15, 2019

SELL
$77.77 - $120.68 $785,477 - $1.22 Million
-10,100 Reduced 77.69%
2,900 $231,000
Q1 2019

May 16, 2019

BUY
$91.83 - $120.68 $459,150 - $603,400
5,000 Added 62.5%
13,000 $1.45 Million
Q3 2018

Nov 14, 2018

SELL
$88.49 - $127.55 $433,601 - $624,995
-4,900 Reduced 37.98%
8,000 $1.01 Million
Q2 2018

Aug 15, 2018

BUY
$60.0 - $85.67 $288,000 - $411,216
4,800 Added 59.26%
12,900 $1.08 Million
Q1 2018

May 15, 2018

SELL
$52.72 - $67.25 $326,864 - $416,950
-6,200 Reduced 43.36%
8,100 $498,000
Q4 2017

Feb 15, 2018

BUY
$58.2 - $72.76 $23,280 - $29,104
400 Added 2.88%
14,300 $835,000
Q3 2017

Nov 14, 2017

BUY
$57.01 - $118.75 $792,439 - $1.65 Million
13,900
13,900 $807,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.